Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218395
Max Phase: Preclinical
Molecular Formula: C43H71N13O16
Molecular Weight: 1026.12
Molecule Type: Small molecule
Associated Items:
ID: ALA3218395
Max Phase: Preclinical
Molecular Formula: C43H71N13O16
Molecular Weight: 1026.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCCCCCCc2cn(CCCCCCCNC(=O)O[C@@H]([C@@H]3OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]3NC(C)=O)[C@H](O)CO)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C43H71N13O16/c1-23(59)50-32-26(52-40(44)45)18-30(38(63)64)69-36(32)34(28(61)21-57)71-42(67)48-15-11-7-4-3-6-10-14-25-20-56(55-54-25)17-13-9-5-8-12-16-49-43(68)72-35(29(62)22-58)37-33(51-24(2)60)27(53-41(46)47)19-31(70-37)39(65)66/h18-20,26-29,32-37,57-58,61-62H,3-17,21-22H2,1-2H3,(H,48,67)(H,49,68)(H,50,59)(H,51,60)(H,63,64)(H,65,66)(H4,44,45,52)(H4,46,47,53)/t26-,27-,28+,29+,32+,33+,34+,35+,36+,37+/m0/s1
Standard InChI Key: YRDZTIWSUHENEO-NULBBPQXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1026.12 | Molecular Weight (Monoisotopic): 1025.5142 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):